Chapter 1691: : Chen Cang is here!

　　 Taidanis is not a person who likes to attend meetings.
　　 He thinks that researchers just need to communicate with their peers, not with those capitalists.
Of course!
　　 The capitalists need to coax, after all, it is the father of the funder, the ATM machine, and they need to ask for money from them regularly.
　　 So, for this kind of academic conference held by bosses, he just smiled and refused.
　　 then came back and threw him into the trash can.
　　 John smiled and said, "Maybe we can touch the opportunity, what do you think?"
　　 Taidanis nodded: "Okay!"
　　 He is now without his former glory.
　　Everything must come from the beginning.
　　Sometimes, I’m not afraid of having no money and skills, but because I don’t have the humble heart I used to be.
　　 Taidanis adjusted his mentality in one day. From a person who is confident to hit the Nobel Prize, to start over, all this is by no means that simple.
　　He took the ticket seriously, opened it with a smile, and put it to his mouth: "I smell hope!"
　　……
　　……
　　 Chen Cang got off the plane, and Yotel from Nature magazine came to pick him up.
　　 When Chen Cang told Yotel that he wanted to recruit people and attract investment.
　　Yottle invited Chen Cang to attend this conference in New York.
　　 There were many investors at this conference, many engineers from pharmaceutical companies, and many researchers and laboratories looking for investors.
　　 These meetings are like a small venture capital market.
　　 It's just that these investments are scientific research investments, and the purchases are all hope.
　　 However, these companies are not stupid. In fact, they are more not investing, but acquiring patents.
　　 After all, it is much cheaper to train a group of people to invest in R&D than to buy directly, and even these laboratories have outsourced functions.
For example, Pfizer is doing well in oncology drugs. There are some small issues that it wants to develop, but there is no relevant team. The investment in training is too large and the cycle is too long. At this time, he will not choose to cooperate with Johnson & Johnson and Roche. Will outsource small problems.
　　Many small laboratories are actually the main way to make money in this way.
　　 So foreign scientific research institutions can even be said to be blooming everywhere, this is not an exaggeration.
　　 Of course, for those star projects, these companies have money and can invest, let you study them.
　　 For example, the x-pri technology of Howard's Axe Company at that time was favored by Johnson & Johnson and directly exchanged shares and invested.
　　 Chen Cang is here today, and his purpose is very simple, asking for money!
　　 But!
　　He doesn't want to sell Parkinson's technology so early, he is here to sell another technology.
　　 New stereotactic technology!
　　 Chen Cang is short of money now. There is nothing he can do. Now Wanhe Group has just started, and the plant and equipment assembly lines are all spending money.
　　 There is also a four-legged gold swallowing beast in the UK who is developing cardio cardioplegia, which is also costly.
just now!
　　 Chen Cang, the scientific research laboratory here, also thought about cooperating with the Chinese Academy of Sciences, the Ministry of Science and Technology, and the Health Commission.
　　 But after thinking for a long time, Chen Cang refused!
　　 After all, as long as you ask for money from others.
　　 You are destined to accept the management of others.
　　 This is the policy!
　　 So, instead of doing this, it's better to find a way to make money yourself.
　　 He didn't want to sell his shares to capitalists.
　　 I don't want to transfer Parkinson's technology yet.
　　After thinking and thinking, the most suitable one is the reward "New Stereotactic Instrument".
　　 Besides, there is one more!
　　 That is the guide production of Google’s microscope stereo imaging technology only by itself.
　　 During this time, Bruce, the person in charge of the project at Google, and Walter, the chief engineer, also came to New York to meet this time.
　　 Chen Cang is about these two things this time.
　　 see how much you can sell!
　　 It's best to pack and sell.
　　 In fact, Chen Cang is more inclined to complete the acquisition by Google.
　　 Because he knows that Google has such capabilities.
　　Moreover, microscopic imaging technology and new stereotactic instruments can be combined.
　　 Once combined, the effect will be more significant!
　　 Why didn't Chen Cang sell it to China?
　　 is very simple...
　　 The price is not high!
　　Chen Cang is not doing public welfare.
　　 He also wants to buy a good price.
　　 On the same day, the editor-in-chief of "Nature" Yotel took Chen Cang to the hotel for a little rest, then arrived at the venue.
　　 Chen Cang does not have much time to delay.
　　 The week-long appointment has reached the sixth day!
　　 Tomorrow, Chen Cang will return home with a huge sum of money.
　　 His heart price is 500 million US dollars!
　　With these 500 million dollars in hand, he believes that the construction of the laboratory should not be a big problem, right?
　　 The meeting has not yet started at this time, but there are already many people in the huge venue.
The arrival of 　　Yotel attracted the attention of many people.
　　 is the editor-in-chief of Nature after all, and his status is still very high.
　　 However, when Yotel introduced Chen Cang to everyone, he immediately attracted everyone's attention in the room.
　　 "Chen Cang! Professor Chen?"
　　 "That surgical genius?"
　　 "No, he is a scientific research wizard now!"
　　 "Yes, I read that paper, and it makes sense. Professor Chen Cang has a better understanding of Parkinson's than everyone, including Professor Tydanis!"
　　 "It turned out to be Professor Chen! Why did he come?"
　　 "Is it...for patents?"
　　 One time!
　　 When Chen Cang appeared at the conference, more and more people began to call the company.
　　New York is an international city, and many large pharmaceutical groups have subsidiaries here.
　　 After learning that Chen Cang was present at the venue, he immediately dispatched the branch manager to arrive here, and be sure to keep in touch with the head office at any time.
　　 This time, Chen Cang's research on Parkinson has attracted the attention of these large pharmaceutical companies.
　　Chen Cang is simply a tempting sweet pastry in the eyes of everyone!
　　 In the afternoon, when Tedanis and John arrived at the venue with relevant research results, UU read www.uukanshu.com for a moment.
　　Tedanis is someone who has seen big scenes, but...even so, I was a little surprised.
　　 Why are there so many bosses in this venue?
　　 Most of the giants of New York pharmaceutical companies came, and the general manager level came in person.
　　 This scene shocked Tedanis a bit!
　　 Why on earth?
what happened?
　　 But, soon he learned the reason.
　　Because he was in the crowd, he saw a familiar figure: Chen Cang!
　　 After seeing it, Taidanis' heart is full of mixed flavors.
　　I used to be aloof, and even wanted to calculate Chen Cang and get the results of his research on Parkinson.
　　Now...
　　 At such a meeting.
　　 Chen Cang has become the existence of Zhongxing Pengyue, but he... Few people care about it.
　　In the eyes of capital, he is no longer the first person in the Parkinson field.
　　 Thinking of this, if Tedanis said he did not regret it, it would definitely be a lie.
　　 There really is a chance to turn around, he will never refuse!
　　
　　 Please remember the domain name of the book’s first publication:. The fastest mobile version update URL: